Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MOSPD3 Activators

MOSPD3 Activators are a diverse array of chemical compounds that target various biochemical pathways to enhance the functional activity of MOSPD3. For instance, Forskolin and 8-Bromo-cAMP function by increasing intracellular cAMP levels, thereby activating PKA, which is known to phosphorylate various substrates. This activation can lead to changes in cellular processes such as cytoskeletal dynamics and motility, potentially enhancing the activity of MOSPD3 in these contexts. Similarly, PMA, a PKC activator, and Bisindolylmaleimide I, a PKC inhibitor, modulate PKC signaling, which is implicated in the regulation of cell motility and organization. The modulation of these pathways can lead to an indirect enhancement of MOSPD3's function. Ionomycin and Thapsigargin, by disrupting calcium homeostasis, can also enhance MOSPD3's activity through the influence of calcium-dependent signaling pathways. Oleic Acid impacts cell membrane dynamics, potentially affecting the interaction of MOSPD3 with other proteins or cellular components, leading to the enhancement of its activity.

The influence of lipid signaling is further exemplified by Sphingosine-1-phosphate (S1P), which activates G-protein-coupled receptors that can result in the modulation of cytoskeletal organization, where MOSPD3 may be functionally active. Inhibition of specific kinases and pathways also plays a critical role in modulating MOSPD3's activity. U0126 and Wortmannin, both inhibitors of key signaling molecules within the MAPK/ERK and PI3K/AKT pathways, respectively, could indirectly increase MOSPD3's activity by altering the balance of intracellular signaling. Additionally, Epigallocatechin gallate (EGCG) broadly inhibits kinases, potentially allowing for MOSPD3 activity enhancement through its effects on cell signaling pathways. Collectively, these activators work through various mechanisms to influence the cellular environment and signaling landscape, thus promoting the functional activity of MOSPD3 without directly impacting its expression levels.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is known to inhibit multiple kinases and has been implicated in the modulation of cell signaling pathways. This broad inhibition could lead to enhanced MOSPD3 activity by affecting the signaling pathways that regulate the processes in which MOSPD3 is involved.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

As a specific inhibitor of PKC, Bisindolylmaleimide I affects PKC-mediated signaling. This could lead to the enhanced activity of MOSPD3 by modulating cellular processes that are influenced by PKC signaling and are relevant to the function of MOSPD3.